3B Pharmaceuticals GmbH (3BP) is a biotechnology company founded in 2008, located in Berlin, Germany. The company focuses on the development of targeted radiopharmaceutical therapeutics and diagnostics for oncology indications with high unmet medical needs. As a privately held pharmaceutical R&D company, 3BP is dedicated to addressing critical gaps in cancer treatment. Notably, it has garnered attention for its innovative approach towards addressing challenges in the field of oncology. Although specific details about the last investment round and involved investors are not available at this time, 3BP's aim to make significant strides in the development of advanced pharmaceutical solutions indicates potential for further growth and impact within the biotechnology sector.
There is no investment information
No recent news or press coverage available for 3B Pharmaceuticals GmbH.
We care about your data, and we'd love to use cookies make your experience better.
